Document is current
Any future updates will be listed below
-
Authors
Jalkanen, Juho
Khan, Sofia
Elima, Kati
Huttunen, Teppo
Wang, Ning
Hollmén, Maija
Elo, Laura L.
Jalkanen, Sirpa
-
Funding
Funding for this research was provided by:
Seventh Framework Programme
Academy of Finland
Sigrid Juselius Foundation
Jane ja Aatos Erkon Säätiö
- License Information
-
More Information
Article History
Received: 17 October 2022
Accepted: 1 March 2023
First Online: 16 March 2023
Declarations
:
: Genetic analyses are part of the multi-center INTEREST trial (ClinicalTrials.gov Identifier: NCT02622724<u>)</u>. The trial was approved by the national regulatory authorities and central/local ethics boards, and written informed consent was obtained in accordance with local processes. Anonymous lung specimens were collected with the permission from the ethics authorities at Turku University Hospital (Finland).
: Not applicable.
: JJ is an employee and TH consultant of Faron Pharmaceuticals, JJ, MH, and SJ own stocks of Faron Pharmaceuticals.
